Melanson Julien, Kachmar Jessica, Laurin Louis-Philippe, Elftouh Naoual, Nadeau-Fredette Annie-Claire
Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.
Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.
Can J Kidney Health Dis. 2022 Jul 18;9:20543581221113387. doi: 10.1177/20543581221113387. eCollection 2022.
Kidney failure prevalence is increasing in older patients for whom dialysis initiation can be challenging. Assisted peritoneal dialysis (PD), where PD is performed with the help of a healthcare worker, can facilitate PD for frailer patients who may not be candidate otherwise.
This study aimed to assess the feasibility of implementing the first pilot assisted PD program in Quebec (Canada) and to evaluate the characteristics and outcomes of the PD cohort before and after assisted PD availability.
Observational retrospective cohort study.
All adult patients initiating PD between 2015 and 2020 in a single-center dialysis unit were included.
Incidence, characteristics, and outcomes of patients with PD were compared between (1) the "pre" (2015-2017) and the "post" assisted PD era (2018-2020) and (2) patients with assisted PD and independent PD in the more recent period.
The primary outcome was peritonitis rate over the first year. Secondary outcomes included hospitalization, transfers to in-center hemodialysis (HD) and mortality.
Overall, 124 patients initiated PD with an annual incidence of 17 ± 3 patients during the "pre" and 24 ± 8 patients during the "post" assisted PD era ( = .18). First-year peritonitis rate was similar over the 2 eras. Years of PD initiation and use of assisted PD were not associated with risk peritonitis (over total follow-up) after adjustment. Adjusted hazard of transfer to HD or death was higher during the "post" era (hazard ratio [HR]: 2.77; 95% confidence interval [CI]: 1.42-5.58). Seventeen patients received assisted PD including 13 (18%) of the 72 patients initiated between 2018 and 2020. Patients with assisted PD were older than those with independent PD (72 [64-84] vs. 59 [47-67], = .006) and received assistance for 0.8 (0.4-1.5) years. When comparing assisted and independent cohorts, there were no differences in crude rates of peritonitis or hospitalization.
Single-center study with small sample size.
This study shows the feasibility of implementing an assisted PD program, with favorable overall outcomes including similar rates of peritonitis during the first year after PD initiation.
老年患者肾衰竭患病率正在上升,对他们而言开始透析可能具有挑战性。辅助腹膜透析(PD)是在医护人员帮助下进行的腹膜透析,对于那些可能无法自行进行腹膜透析的体弱患者而言,它有助于实施腹膜透析。
本研究旨在评估在魁北克(加拿大)实施首个辅助腹膜透析试点项目的可行性,并评估辅助腹膜透析实施前后腹膜透析队列的特征和结局。
观察性回顾性队列研究。
纳入了2015年至2020年在单中心透析单元开始进行腹膜透析的所有成年患者。
比较(1)“前”(2015 - 2017年)和“后”辅助腹膜透析时代(2018 - 2020年)腹膜透析患者的发病率、特征和结局,以及(2)近期辅助腹膜透析患者和独立腹膜透析患者的情况。
主要结局是第一年的腹膜炎发生率。次要结局包括住院、转至中心血液透析(HD)和死亡率。
总体而言,124例患者开始进行腹膜透析,“前”辅助腹膜透析时代的年发病率为17±3例,“后”辅助腹膜透析时代为24±8例(P = 0.18)。两个时代第一年的腹膜炎发生率相似。调整后,开始腹膜透析的年份和使用辅助腹膜透析与(整个随访期间的)腹膜炎风险无关。“后”时代转至血液透析或死亡的调整后风险更高(风险比[HR]:2.77;95%置信区间[CI]:1.42 - 5.58)。17例患者接受了辅助腹膜透析,其中包括2018年至2020年开始腹膜透析的72例患者中的13例(18%)。接受辅助腹膜透析的患者比独立腹膜透析的患者年龄更大(72[64 - 84]岁对59[47 - 67]岁,P = 0.006),接受辅助的时间为0.8(0.4 - 1.5)年。比较辅助腹膜透析组和独立腹膜透析组时,腹膜炎或住院的粗发生率没有差异。
单中心研究,样本量小。
本研究表明实施辅助腹膜透析项目是可行的,总体结局良好,包括腹膜透析开始后第一年的腹膜炎发生率相似。